Drug-associated nephropathy. Part I: Glomerular lesions.
D002216:Captopril / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D006046:Gold / Q000009:adverse effects; D003932:Heroin / Q000633:toxicity; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D007678:Kidney Glomerulus / Q000473:pathology* / Q000648:ultrastructure; D008628:Mercury / Q000009:adverse effects; D008854:Microscopy, Electron; D010396:Penicillamine / Q000009:adverse effects; D011691:Puromycin / Q000009:adverse effects; D013411:Sulfadiazine / Q000009:adverse effects; D014293:Trimethadione / Q000009:adverse effects
D013411:Sulfadiazine; D011691:Puromycin; D003932:Heroin; D006046:Gold; D002216:Captopril; D008628:Mercury; D010396:Penicillamine; D014293:Trimethadione; D003630:Daunorubicin